Atlas Trials

Effect of Oral 6-bromotryptophan on Safety, Pharmacokinetics and Efficacy in Metabolic Syndrome Individuals

Clinical trial NCT05971524 · UNKNOWN

Trial details

NCT number
NCT05971524
Sponsor
Nordin Hanssen
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metabolic SyndromeDiabetes Mellitus
Start date
2023-05-04
Primary completion
2025-02-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.